NCT04860778 is a Phase 1 clinical trial of BDNF Essentials in Cognitive Change, sponsored by Researched Nutritionals LLC.

Who is sponsoring NCT04860778?

NCT04860778 is sponsored by Researched Nutritionals LLC.

What drugs are being tested in NCT04860778?

Interventions in NCT04860778: BDNF Essentials.

What condition does NCT04860778 study?

NCT04860778 studies Cognitive Change.

Is NCT04860778 still recruiting?

NCT04860778 is currently completed. Last updated 28 April 2022.

Last reviewed 2022-04-28 · How we verify

NCT04860778

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Open-label, Exploratory Study to Investigate the Efficacy of BDNF Essentials® on Cognition

Completed Phase 1 Last updated 28 April 2022

What this trial tests

Phase 1 trial testing BDNF Essentials in Cognitive Change in 20 participants. Completed in 10 September 2021.

Timeline

27 April 2021

Primary endpoint
10 September 2021

10 September 2021

Quick facts

Lead sponsor	Researched Nutritionals LLC
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	27 April 2021
Primary completion	10 September 2021
Estimated completion	10 September 2021
Sites	1 location across Canada

Drugs / interventions tested

BDNF Essentials

Conditions studied

Cognitive Change — all drugs for Cognitive Change →

Sponsor

Researched Nutritionals LLC

Who can join

45 and older, any sex, with Cognitive Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this open-label, exploratory study is to investigate the efficacy of BDNF Essentials® on cognition in a healthy adult population with self-reported memory complaints. As there is a dearth of available literature on BDNF in this study population, the current study is designed to understand the role of BDNF to inform potential future studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cognitive Change

Currently open trials in the same condition.

NCT07147894 — Executive Function Training for Children and Adolescents · NA · recruiting
NCT07383324 — Heat Stress in Individuals With Schizophrenia · NA · recruiting
NCT07261202 — Impact of Indoor Overheating on Physiological Strain in Children · NA · recruiting
NCT07267598 — Suitability of a 26 °C Indoor Environment for Mitigating Heat Strain in Young Adults · NA · recruiting
NCT07054723 — Surviving Daily Life · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04860778 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Researched Nutritionals LLC
Last refreshed: 28 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04860778.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing